Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

2019 Proteomic and Metabolomic Approaches to Biomarker Discovery. Edition No. 2 - Standard Operating Procedure for Sample Selection, Preparation & Storage, as well as Data Analysis & Modeling - ResearchAndMarkets.com

November 25, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Nov 25, 2019--

The “Proteomic and Metabolomic Approaches to Biomarker Discovery. Edition No. 2” book from Elsevier Science and Technology has been added to ResearchAndMarkets.com’s offering.

Proteomic and Metabolomic Approaches to Biomarker Discovery, Second Edition covers techniques from both proteomics and metabolomics and includes all steps involved in biomarker discovery, from study design to study execution. The book describes methods and presents a standard operating procedure for sample selection, preparation and storage, as well as data analysis and modeling. This new standard effectively eliminates the differing methodologies used in studies and creates a unified approach. Readers will learn the advantages and disadvantages of the various techniques discussed, as well as potential difficulties inherent to all steps in the biomarker discovery process.

This second edition has been fully updated and revised to address recent advances in MS and NMR instrumentation, high-field NMR, proteomics and metabolomics for biomarker validation, clinical assays of biomarkers and clinical MS and NMR, identifying microRNAs and autoantibodies as biomarkers, MRM-MS assay development, top-down MS, glycosylation-based serum biomarkers, cell surface proteins in biomarker discovery, lipodomics for cancer biomarker discovery, and strategies to design studies to identify predictive biomarkers in cancer research.

  • Addresses the full range of proteomic and metabolomic methods and technologies used for biomarker discovery and validation
  • Covers all steps involved in biomarker discovery, from study design to study execution
  • Serves as a vital resource for biochemists, biologists, analytical chemists, bioanalytical chemists, clinical and medical technicians, researchers in pharmaceuticals and graduate students

Key Topics Covered:

1. Biomarker discovery: Study design and execution

2. Proteomic and mass spectrometry technologies for biomarker discovery

3. Tissue sample preparation for proteomic analysis

4. Sample preparation in global metabolomics of biological fluids and tissues

5. Serum and plasma collection: Preanalytical variables and standard operating procedures in biomarker research

6. Sample depletion, fractionation, and enrichment for biomarker discovery

7. Current NMR strategies for biomarker

8. Gas chromatography/mass spectrometrybased metabonomics

9. Liquid chromatographic methods combined with mass spectrometry in metabolomics

10. Capillary electrophoresis-mass spectrometry for proteomic and metabolic

11. Associating 2-DE and CPLLs for low-abundance protein discovery: A winning strategy

12. Two-dimensional difference in gel electrophoresis for biomarker discovery

13. Affinity-targeting schemes for protein biomarkers

14. Protein and metabolite identification

15. Quantitative proteomics in development of disease protein biomarkers

16. Mass spectrometry and NMR spectroscopy based quantitative metabolomics

17. Top-down mass spectrometry for protein molecular diagnostics, structure analysis, and biomarker discovery

18. Using data-independent mass spectrometry to extend detectable dynamic range without prior fractionation

19. Imaging mass spectrometry of intact biomolecules in tissue section

20. Mass spectrometry-based approach for protein biomarker verification

21. Mass spectrometry metabolomic data handling for biomarker discovery

22. Analytical methods and biomarker validation

23. Multivariate analysis for metabolomics and proteomics data

24. Cell surface protein enrichment for biomarker and drug target discovery using mass spectrometry-based proteomic

25. Advances in lipidomics for cancer biomarker discovery

26. Mass spectrometry for the identification of protein biomarkers in urinary extracellular vesicles

27. Designing clinical studies for biomarker discovery: The DESIGN criteria


  • Issaq, Haleem J.
  • Veenstra, Timothy D.

For more information about this book visit https://www.researchandmarkets.com/r/1r7mtd

View source version on businesswire.com:https://www.businesswire.com/news/home/20191125005457/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/25/2019 08:23 AM/DISC: 11/25/2019 08:23 AM